Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 01 Jul 2024

Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cells

in Thoracic Oncology

Hanna Sentek
Annika Braun
Bettina Budeus
Diana Klein

Frontiers in Oncology

doi 10.3389/fonc.2024.1406268

3,262 views
11 citations

Original Research

Published on 01 Jul 2024

Nomogram for predicting invasive lung adenocarcinoma in small solitary pulmonary nodules

in Thoracic Oncology

Mengchao Xue
Rongyang Li
Junjie Liu
Ming Lu
Zhenyi Li
Huiying Zhang
Hui Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1334504

2,472 views
1 citation

Original Research

Published on 25 Jun 2024

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

in Thoracic Oncology

Ni Sun
Ru Li
Haiyi Deng
Qingyang Li
Jiaxi Deng
Yue Zhu
Wenwei Mo
Wenhui Guan
Minjuan Hu
Ming Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1372532

2,547 views
1 citation

Original Research

Published on 25 Jun 2024

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy

in Thoracic Oncology

Min Zhang
Liang Zhu
Sibei Liang
Zhirong Mao
Xiaolin Li
Lingge Yang
Yan Yang
Kai Wang
Pingli Wang
Weiyu Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1411436

2,827 views
3 citations

Case Report

Published on 24 Jun 2024

Case report: Precise NGS and combined bevacizumab promote durable response in ALK-positive lung adenocarcinoma with multiple-line ALK-TKI resistance

in Thoracic Oncology

Jin Xiong
Lei Xia

Frontiers in Oncology

doi 10.3389/fonc.2024.1419306

1,956 views
1 citation

Original Research

Published on 24 Jun 2024

Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer

in Thoracic Oncology

Shixin Ma
Lunqing Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1396843

2,547 views
13 citations

Original Research

Published on 21 Jun 2024

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

in Thoracic Oncology

Blake J. McKinley
Tanmayi S. Pai
Emily B. Wolf
Shenduo Li
Guilherme Sacchi de Camargo Correia
Yujie Zhao
Rami Manochakian
Yanyan Lou

Frontiers in Oncology

doi 10.3389/fonc.2024.1417175

3,225 views
1 citation

Review

Published on 21 Jun 2024

Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer

in Thoracic Oncology

Xiaochen Wang
Lu Bai
Linghui Kong
Zhijuan Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1411731

3,851 views
5 citations

Case Report

Published on 21 Jun 2024

EGFR kinase domain duplication in lung adenocarcinoma with systemic and intracranial response to a double-dose of furmonertinib: a case report and literature review

in Thoracic Oncology

Hong Lin
Zhengyuan Yang
Zhifeng Li
Junwei Chen
Hongbiao Wang
Yingcheng Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1321587

1,960 views
2 citations

Original Research

Published on 20 Jun 2024

Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer

in Thoracic Oncology

Han Qiao
Yan Feng
Xiaolei Han
Huaping Tang

Frontiers in Oncology

doi 10.3389/fonc.2024.1393684

1,587 views

Mini Review

Published on 18 Jun 2024

Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer

in Thoracic Oncology

Hongyan Li
Lina Xu
Hongshun Cao
Tianyi Wang
Siwen Yang
Yixin Tong
Linlin Wang
Qiang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1405380

4,329 views
12 citations

Original Research

Published on 18 Jun 2024

Causal association of circulating cytokines with the risk of lung cancer: a Mendelian randomization study

in Thoracic Oncology

Dachen Luo
Zonglian Gong
Qingyuan Zhan
Shan Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1373380

3,068 views
2 citations

Case Report

Published on 18 Jun 2024

Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review

in Thoracic Oncology

Yanzhu Qin
Shuaiji Lu
Jingwen Chen
Jing Peng
Jijun Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1415748

2,422 views
3 citations

Original Research

Published on 17 Jun 2024

CT radiomics to differentiate neuroendocrine neoplasm from adenocarcinoma in patients with a peripheral solid pulmonary nodule: a multicenter study

in Thoracic Oncology

Xiaoyu Liu
Hongjian Li
Shengping Wang
Shan Yang
Guobin Zhang
Yonghua Xu
Hanfeng Yang
Fei Shan

Frontiers in Oncology

doi 10.3389/fonc.2024.1420213

1,838 views
3 citations

Case Report

Published on 17 Jun 2024

Gastrointestinal stromal tumor with small cell carcinoma infiltration: a case report

in Thoracic Oncology

Yitong Zhou
Liyuan Song
Li Lyu
Shengjie Li
Qimin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1389975

1,411 views

Systematic Review

Published on 11 Jun 2024

The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review

in Thoracic Oncology

Yutaka Fujiwara
Kazuhiro Shimomura
Teppei Yamaguchi
Junichi Shimizu
Naohiro Watanabe
Reiko Matsuzawa
Kenta Murotani
Yoshitsugu Horio

Frontiers in Oncology

doi 10.3389/fonc.2024.1419256

4,542 views
5 citations

Review

Published on 11 Jun 2024

The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation

in Thoracic Oncology

Xiuyue Man
Xueru Sun
Chen Chen
Yan Xiang
Jing Zhang
Lei Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1367204

4,202 views
3 citations

Editorial

Published on 07 Jun 2024

Editorial: Real-world data and real-world evidence in lung cancer

in Thoracic Oncology

Valerio Gristina
Chukwuka Eze

Frontiers in Oncology

doi 10.3389/fonc.2024.1436077

2,212 views
6 citations

Review

Published on 06 Jun 2024

Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma

in Thoracic Oncology

Haitao Wei
Sa Zhang
Xiaojin Lin
Ruirui Fang
Li Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1411672

2,040 views

Case Report

Published on 06 Jun 2024

A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review

in Thoracic Oncology

Cong Yin
Zheng-jia Liu
Chao He
Hai-xiang Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1399868

2,530 views
4 citations

Case Report

Published on 06 Jun 2024

Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance

in Thoracic Oncology

Wanming He
Lihua Tong
Wen Yang
Yanling Yuan
Yu Li
Wubing Tang

Frontiers in Oncology

doi 10.3389/fonc.2024.1298389

2,704 views
3 citations

Original Research

Published on 04 Jun 2024

SIRPG promotes lung squamous cell carcinoma pathogenesis via M1 macrophages: a multi-omics study integrating data and Mendelian randomization

in Thoracic Oncology

Guocai Mao
Jing Li
Nan Wang
Hongbin Yu
Shiyu Han
Mengqi Xiang
Huachuan Zhang
Daxiong Zeng
Junhong Jiang
Haitao Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1392417

4,398 views
9 citations

Original Research

Published on 03 Jun 2024

Predictive model based on multiple immunofluorescence quantitative analysis for pathological complete response to neoadjuvant immunochemotherapy in lung squamous cell carcinoma

in Thoracic Oncology

Meng Xiao
Lili Tu
Ting Zhou
Ye He
Xiaohui Li
Qiunan Zuo

Frontiers in Oncology

doi 10.3389/fonc.2024.1396439

1,823 views

Systematic Review

Published on 03 Jun 2024

Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis

in Thoracic Oncology

Yuxiang Liang
Haidi Xu
Futao Liu
Lei Li
ChenXi Lin
Yaozhong Zhang
Na Wang
Lei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1281645

3,651 views
11 citations

1,912 articles

articles

Non-small cell lung cancer cells and concomitant cancer therapy induce a resistance-promoting phenotype of tumor-associated mesenchymal stem cells

Nomogram for predicting invasive lung adenocarcinoma in small solitary pulmonary nodules

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy

Case report: Precise NGS and combined bevacizumab promote durable response in ALK-positive lung adenocarcinoma with multiple-line ALK-TKI resistance

Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

Advances in circulating tumor cells for early detection, prognosis and metastasis reduction in lung cancer

EGFR kinase domain duplication in lung adenocarcinoma with systemic and intracranial response to a double-dose of furmonertinib: a case report and literature review

Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer

Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer

Causal association of circulating cytokines with the risk of lung cancer: a Mendelian randomization study

Case report: A rare case of anti-PD-1 sintilimab-induced agranulocytosis/severe neutropenia in non-small cell lung cancer and literature review

CT radiomics to differentiate neuroendocrine neoplasm from adenocarcinoma in patients with a peripheral solid pulmonary nodule: a multicenter study

Gastrointestinal stromal tumor with small cell carcinoma infiltration: a case report

The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review

The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation

Editorial: Real-world data and real-world evidence in lung cancer

Differential expression and clinical significance of long non-coding RNAs in the development and progression of lung adenocarcinoma

A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review

Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance

SIRPG promotes lung squamous cell carcinoma pathogenesis via M1 macrophages: a multi-omics study integrating data and Mendelian randomization

Predictive model based on multiple immunofluorescence quantitative analysis for pathological complete response to neoadjuvant immunochemotherapy in lung squamous cell carcinoma

Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis